Cargando…
Down-staging (<pT2) of urothelial cancer at cystectomy after the diagnosis of detrusor muscle invasion (pT2) at diagnostic transurethral resection (TUR): is prediction possible?
Urothelial cell carcinoma (UCC) with musculus detrusor (MD) invasion is treated by cystectomy. Subsequent pathologic evaluation of cystectomies does not reveal MD invasion (<pT2) in a subgroup of patients. Our objective was to identify features at diagnostic transurethral resection (TUR) predicti...
Autores principales: | Beukers, Willemien, Meijer, Titia, Vissers, Cornelis J., Boormans, Joost L., Zwarthoff, Ellen C., van Leenders, Geert J. L. H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3421107/ https://www.ncbi.nlm.nih.gov/pubmed/22777576 http://dx.doi.org/10.1007/s00428-012-1277-0 |
Ejemplares similares
-
Tranexamic acid decreases blood loss during transurethral resection of the prostate (TUR -P)
por: Kumsar, Şükrü, et al.
Publicado: (2011) -
Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2015) -
Slingshot homolog-1 expression is a poor prognostic factor of pT1 bladder urothelial carcinoma after transurethral resection
por: Luo, Qiang, et al.
Publicado: (2020) -
Outcomes and Prognostic Factors of Patients with Urothelial Carcinoma Undergoing Radical Cystectomy and pT0 in the Final Histology Without Neoadjuvant Chemotherapy
por: Rodler, Severin, et al.
Publicado: (2022) -
AB180. Impact of lymphovascular invasion on recurrence and progression rates in patients with pT1 urothelial carcinoma of bladder after transurethral resection
por: Sha, Nan, et al.
Publicado: (2016)